CF Pharma Cisatracurium Besylate Header CF Pharma Cisatracurium Besylate Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Cisatracurium Besylate

    Client Email Product

    Cisatracurium Besylate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    25
    US DMFs Filed

    US DMFs Filed

    10
    CEP/COS Certifications

    CEP/COS Certifications

    5
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    18
    API REF. PRICE (USD / KG)
    37,827

    API Market Place

    13
    INTERMEDIATES
    9
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    44
    Europe

    Europe

    2
    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    11
    Uploaded Dossiers

    Uploaded Dossiers

    28
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    10
    EXCIPIENTS
    4
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    25
    REF STANDARD

    EDQM

    1

    USP

    2

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - EQ 10MG BASE/ML
    • INJECTABLE;INJECTION - EQ 2MG BASE/ML
    Full View ScreenFull Screen View
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.
    Hainan Poly`s Generic Cisatracurium Besylate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216538

    FDA
    08 Mar 2024
    Share Share
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Caplin's Generic Cisatracurium Besylate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217725

    FDA
    09 Jun 2023
    Share Share
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients

    http://cfpharma.hu/development-of-manufacturing-technology-for-three-pharmaceutical-ingredients/

    PRESS RELEASE
    30 Jan 2023
    Share Share
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.
    Piramal's Generic Cisatracurium Besylate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212432

    FDA
    11 Mar 2022
    Share Share
    Enforcement Report - Week of March 3, 2021
    Enforcement Report - Week of March 3, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf

    FDA
    03 Mar 2021
    Share Share
    Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection
    Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection

    https://www.pharmacompass.com/pdf/news/meitheal-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-cisatracurium-besylate-injection-1612589041.pdf

    FDA
    28 Jan 2021
    Share Share
    Zydus Cadila gets US FDA approval for Cisatracurium Besylate Injection
    Zydus Cadila gets US FDA approval for Cisatracurium Besylate Injection

    https://www.expresspharma.in/latest-updates/zydus-cadila-gets-us-fda-approval-for-cisatracurium-besylate-injection/

    EXPRESSPHARMA
    02 Sep 2020
    Share Share
    Zydus Cadila receives US FDA approval to market cisatracurium besylate injection
    Zydus Cadila receives US FDA approval to market cisatracurium besylate injection

    http://www.pharmabiz.com/NewsDetails.aspx?aid=130799&sid=2

    PHARMABIZ
    01 Sep 2020
    Share Share
    Piramal Healthcare Generic's Cisatracurium Besylate Reveives Approval in US
    Piramal Healthcare Generic's Cisatracurium Besylate Reveives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212190

    FDA
    06 May 2020
    Share Share
    Boots consultation rooms to become ‘safe spaces’ for patients
    Boots consultation rooms to become ‘safe spaces’ for patients

    https://www.pharmaceutical-journal.com/news-and-analysis/news-blog/covid-19-latest-boots-consultation-rooms-to-become-safe-spaces-for-patients-facing-domestic-abuse/20207843.article?firstPass=false

    PHARMACEUTICAL-JOURNAL
    01 May 2020
    Share Share
    Wavelength Ups API Production for Essential Respiratory Meds
    Wavelength Ups API Production for Essential Respiratory Meds

    https://www.contractpharma.com/contents/view_breaking-news/2020-04-20/wavelength-ups-api-production-for-essential-respiratory-meds/

    CONTRACTPHARMA
    20 Apr 2020
    Share Share
    Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
    Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19

    https://www.biospace.com/article/releases/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/

    BIOSPACE
    20 Apr 2020
    Share Share
    Accord Healthcare addresses shortages critical ventilator medicines for COVID-19
    Accord Healthcare addresses shortages critical ventilator medicines for COVID-19

    https://www.accord-healthcare.com/newsroom/accord-healthcare-addresses-shortages-critical-ventilator-medicines-covid-19-patients

    ACCORD-HEALTHCARE
    17 Apr 2020
    Share Share
    CORRECTING & REPLACING Vizient Applauds FDA’s Temporary Policy Compounding
    CORRECTING & REPLACING Vizient Applauds FDA’s Temporary Policy Compounding

    https://www.businesswire.com/news/home/20200416005949/en

    BUSINESSWIRE
    17 Apr 2020
    Share Share
    Zydus Pharms USA`s Generic Ramelteon Receives Approval in US
    Zydus Pharms USA`s Generic Ramelteon Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212171

    FDA
    07 Nov 2019
    Share Share
    Zydus Cadila gets US FDA approval for generic muscle relaxing injection
    Zydus Cadila gets US FDA approval for generic muscle relaxing injection

    https://www.business-standard.com/article/pti-stories/zydus-cadila-gets-usfda-nod-for-generic-muscle-relaxing-injection-119110500480_1.html

    BUSINESS-STANDARD
    05 Nov 2019
    Share Share
    CF Pharma received HALAL certification
    CF Pharma received HALAL certification

    http://cfpharma.hu/archive/cf-pharma-received-halal-certification-copy-copy/

    PRESS RELEASE
    06 Jul 2019
    Share Share
    Nanjing King-Friend`s Generic Cisatracurium Besylate Receives Approval in US
    Nanjing King-Friend`s Generic Cisatracurium Besylate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211669

    FDA
    30 Apr 2019
    Share Share
    Somerset Theraps` Generic Cisatracurium besylate Receives Approval in US
    Somerset Theraps` Generic Cisatracurium besylate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206791

    FDA
    23 Feb 2019
    Share Share
    Pfizer demands return of drugs set for use in US lethal injections
    Pfizer demands return of drugs set for use in US lethal injections

    https://www.in-pharmatechnologist.com/Article/2017/11/21/Pfizer-demands-return-of-drugs-set-for-use-in-US-lethal-injections

    Dan Stanton IN PHARMATECHNOLOGY
    22 Nov 2017
    Share Share
    Jiangsu Hengrui Med’s Generic Cisatracurium Besylate Receives Approval In US
    Jiangsu Hengrui Med’s Generic Cisatracurium Besylate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209334

    FDA
    01 Sep 2017
    Share Share
    Accord Hlthcare’s Generic Cisatracurium Besylate Receives Approval In US
    Accord Hlthcare’s Generic Cisatracurium Besylate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205872

    FDA
    20 Jun 2017
    Share Share
    Jiangsu Hengrui's Generic Cisatracurium Besylate Receives Approval In US
    Jiangsu Hengrui's Generic Cisatracurium Besylate Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204960

    FDA
    27 Jan 2017
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews
    Japan MHLW panel names 11 unapproved/off-label drugs for fast-track reviews

    http://www.fiercepharmaasia.com/story/japan-mhlw-panel-names-11-unapprovedoff-label-drugs-fast-track-reviews/2015-04-27

    Ej Lane FIERCE PHARMA ASIA
    28 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Cisatracurium Besylate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search